GABRG2 rs77905: Understanding This Epilepsy-Associated Variant
The rs77905 variant is a genetic polymorphism located within the GABRG2 gene, which encodes a critical subunit of the GABA-A receptor. Research has identified this variant as being associated with a genetic predisposition to various epilepsy syndromes.
What each genotype means
Common genetic profile
This genotype represents the most frequently observed sequence at this location in the GABRG2 gene. Research into this specific variant does not indicate a significant association with epilepsy syndromes for individuals carrying this combination. As with all genetic findings, this does not rule out other factors that may influence neurological health.
This is the most common genotype found across all major global populations.
Common genetic profile
This genotype is a common variation at this site in the GABRG2 gene. Current scientific literature does not identify this specific combination as a primary driver of epilepsy or other neurological conditions. It is considered a standard variation within the human population.
This genotype is frequently observed in diverse populations worldwide.
Common genetic profile
This genotype is a common sequence variant at this position. There is no evidence in current research to suggest that this specific genotype is associated with an increased risk for epilepsy or other clinical phenotypes. It is regarded as a normal variation in the general population.
This genotype is common and found at varying frequencies across different ancestral groups.
What is the rs77905 Variant?
The rs77905 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that influences the expression or structure of the gamma-aminobutyric acid type A (GABA-A) receptor. Because this receptor is essential for inhibitory neurotransmission in the brain, variations in the genes that encode its subunits can alter how neurons communicate. Scientists study these variants to understand how subtle changes in DNA sequence might contribute to the complex architecture of neurological conditions, including epilepsy. While rs77905 is a recognized marker in genetic studies, it is important to note that the presence of a single variant rarely acts in isolation; rather, it often interacts with other genetic and environmental factors to influence an individual's health profile.
The Role of the GABRG2 Gene
The GABRG2 gene provides instructions for making the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are ligand-gated ion channels that respond to the neurotransmitter GABA, the primary inhibitory chemical messenger in the human central nervous system. When GABA binds to these receptors, they allow chloride ions to flow into neurons, which reduces the likelihood that the neuron will fire an electrical signal. This process is vital for maintaining the balance between excitation and inhibition in the brain. When GABRG2 function is impaired due to genetic variants, this inhibitory "brake" on the brain's electrical activity may be weakened. This imbalance is a well-documented mechanism in the pathophysiology of various epilepsy syndromes. Research into GABRG2 has shown that mutations or polymorphisms in this gene can lead to a spectrum of clinical presentations, ranging from mild febrile seizures to more complex, refractory epileptic encephalopathies.
Research and Evidence Strength
The association between GABRG2 variants and epilepsy is supported by a body of clinical and molecular research. Studies have linked various polymorphisms and mutations in this gene to conditions such as genetic generalized epilepsy, childhood absence epilepsy, and febrile seizures plus. The evidence strength for the association of specific GABRG2 variants with epilepsy is generally considered moderate, as these variants often show incomplete penetrance, meaning not everyone who carries the variant will develop the condition. Furthermore, the clinical expression of these variants can be highly variable even within the same family. While some studies have identified specific polymorphisms as potential predictive markers for epilepsy susceptibility, the field continues to investigate how these variants interact with other genetic modifiers. It is essential to interpret these findings as statistical associations observed in populations rather than deterministic causes for any single individual.
What You Can Do With This Information
Understanding your genetic profile regarding variants like rs77905 can be an educational experience, but it should not be used for self-diagnosis or medical decision-making. If you have concerns about epilepsy or a family history of seizure disorders, the most appropriate step is to consult with a neurologist or a genetic counselor. These professionals can provide context based on your personal medical history, family background, and clinical symptoms. Genetic testing for epilepsy is a specialized field, and results often require expert interpretation to determine their clinical significance. If you are currently taking anti-epileptic medications, never alter your dosage or treatment plan based on genetic information without first discussing it with your prescribing clinician or pharmacist. They are the only ones qualified to integrate your genetic data into a safe and effective clinical management strategy.
How common is this variant?
The rs77905 variant is considered a common polymorphism, with its genotypes appearing at varying frequencies across different global ancestral populations.
Frequently asked questions
Does having the rs77905 variant mean I will develop epilepsy?
No, having this variant does not mean you will develop epilepsy. Epilepsy is a complex condition influenced by many genetic and environmental factors, and many people carry common variants without ever experiencing seizures.
Is rs77905 a diagnostic test for epilepsy?
No, rs77905 is not a diagnostic test. Epilepsy is diagnosed by clinicians based on clinical symptoms, medical history, and diagnostic tools like electroencephalograms (EEGs) and brain imaging.
Should I change my medication if I have this variant?
You should never change your medication based on genetic information without consulting your doctor. Always discuss any concerns about your treatment plan with your healthcare provider or pharmacist.
Where can I find more information about GABRG2?
You can find reliable information about genes and their functions through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs77905?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.